Jane Street
TAK icon

Jane Street’s Takeda Pharmaceutical TAK Stock Holding History

Jane Street’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-106,290
Closed -$1.56M – 12352
2025
Q3 		$1.56M Buy
106,290
+91,318
+610% +$1.36M ﹤0.01% 5404
2025
Q2 		$231K Sell
14,972
-32,134
-68% -$475K ﹤0.01% 8309
2025
Q1 		$700K Sell
47,106
-207,541
-82% -$2.91M ﹤0.01% 6238
2024
Q4 		$3.37M Buy
254,647
+132,817
+109% +$1.82M ﹤0.01% 3251
2024
Q3 		$1.73M Sell
121,830
-481,966
-80% -$6.84M ﹤0.01% 4772
2024
Q2 		$7.81M Buy
603,796
+148,054
+32% +$1.96M ﹤0.01% 2317
2024
Q1 		$6.33M Sell
455,742
-684,087
-60% -$9.95M ﹤0.01% 2307
2023
Q4 		$16.3M Buy
1,139,829
+729,310
+178% +$10.3M ﹤0.01% 1449
2023
Q3 		$6.35M Sell
410,519
-586,670
-59% -$9.08M ﹤0.01% 2301
2023
Q2 		$15.7M Buy
997,189
+941,577
+1,693% +$15.4M 0.01% 1460
2023
Q1 		$916K Buy
+55,612
New +$886K ﹤0.01% 5162
2022
Q4 		– Sell
-412,869
Closed -$5.77M – 10129
2022
Q3 		$5.37M Sell
412,869
-184,474
-31% -$2.57M ﹤0.01% 2501
2022
Q2 		$8.4M Buy
+597,343
New +$8.53M ﹤0.01% 1955
2022
Q1 		– Sell
-56,336
Closed -$827K – 11005
2021
Q4 		$768K Sell
56,336
-306,383
-84% -$4.3M ﹤0.01% 6437
2021
Q3 		$6.03M Buy
362,719
+281,674
+348% +$4.73M ﹤0.01% 2465
2021
Q2 		$1.36M Sell
81,045
-46,717
-37% -$795K ﹤0.01% 5153
2021
Q1 		$2.3M Buy
127,762
+81,794
+178% +$1.47M ﹤0.01% 3748
2020
Q4 		$835K Buy
45,968
+33,586
+271% +$589K ﹤0.01% 4953
2020
Q3 		$220K Sell
12,382
-150,955
-92% -$2.75M ﹤0.01% 6312
2020
Q2 		$2.91M Buy
163,337
+4,143
+3% +$74.4K ﹤0.01% 2554
2020
Q1 		$2.45M Buy
159,194
+76,364
+92% +$1.38M ﹤0.01% 1814
2019
Q4 		$1.65M Sell
82,830
-93,272
-53% -$1.78M ﹤0.01% 2165
2019
Q3 		$3.01M Buy
176,102
+148,675
+542% +$2.57M 0.01% 1400
2019
Q2 		$486K Sell
27,427
-194,684
-88% -$3.54M ﹤0.01% 3613
2019
Q1 		$4.53M Sell
222,111
-579,192
-72% -$11.7M 0.01% 1223
2018
Q4 		$13.5M Buy
+801,303
New +$13.5M 0.03% 445

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's TAK Position: Q4 2025 in Review

Jane Street sold out of Takeda Pharmaceutical (TAK) in Q4 2025, closing a stake of 106,290 shares — an estimated $1.56M sold.

Jane Street first reported a position in TAK in Q4 2018 and held it in 26 quarters. The position peaked at $16.3M in Q4 2023. 348 funds tracked by Wall St. Rank hold TAK as of Q4 2025.

  • Jane Street reported no remaining Takeda Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Jane Street sold 106,290 Takeda Pharmaceutical shares in Q4 2025, an estimated $1.56M.
  • Jane Street first reported a position in Takeda Pharmaceutical in Q4 2018 and held it in 26 quarters.
  • Jane Street's Takeda Pharmaceutical position peaked at $16.3M in Q4 2023.
  • 348 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.